We’re thrilled to announce the launch of our interactive software demo, developed in collaboration with Morehead Design, showcasing QAS.AI’s real-time AI guidance for neuroendovascular procedures.

This milestone marks the transition from prototype to clinical deployment—with our system now live and actively undergoing testing at Gates Vascular Institute, a nationally recognized center for cerebrovascular innovation.

The demo highlights QAS.AI’s ability to:

• Automatically detect aneurysms and injection inlets

• Analyze contrast dynamics from angiographic sequences

• Provide probability-based predictions for aneurysm occlusion at 6 months

• Deliver results in under 1 second, directly in the angio suite

This clinical integration represents a key step toward translating our NSF- and UB CAT-supported research into a standard-of-care decision support tool.